Redhill Biopharma Correlations
| RDHL Stock | USD 5.91 0.02 0.34% |
The current 90-days correlation between Redhill Biopharma and Evoke Pharma is 0.1 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Redhill Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Redhill Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Redhill Biopharma Correlation With Market
Modest diversification
The correlation between Redhill Biopharma and DJI is 0.29 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Redhill Biopharma and DJI in the same portfolio, assuming nothing else is changed.
Redhill |
Moving together with Redhill Stock
Moving against Redhill Stock
| 0.31 | PFE | Pfizer Inc Earnings Call This Week | PairCorr |
| 0.66 | ALTS | ALT5 Sigma Symbol Change | PairCorr |
| 0.58 | ALVO | Alvotech | PairCorr |
| 0.35 | MLAB | Mesa Laboratories Earnings Call This Week | PairCorr |
| 0.57 | CPIX | Cumberland Pharmaceuticals | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Redhill Stock performing well and Redhill Biopharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Redhill Biopharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ORGO | 3.34 | 0.36 | 0.10 | 0.31 | 3.56 | 6.71 | 37.89 | |||
| LFCR | 3.40 | 0.18 | 0.03 | 0.39 | 5.13 | 8.11 | 28.39 | |||
| TARO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| COLL | 1.89 | (0.01) | (0.03) | (0.03) | 2.30 | 3.07 | 17.80 | |||
| AQST | 3.06 | (0.82) | 0.00 | 4.19 | 0.00 | 6.23 | 17.61 | |||
| EVOK | 3.38 | (0.12) | 0.00 | (2.23) | 0.00 | 6.88 | 32.42 | |||
| ADMP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| GHSI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| ACRX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| PTPI | 6.52 | 0.51 | 0.00 | (0.02) | 7.30 | 12.90 | 115.19 |
Redhill Biopharma Corporate Management
| Reza Fathi | Senior Development | Profile | |
| Kristin Comer | G VP | Profile | |
| Valerie Graceffa | VP Sales | Profile | |
| Razi Ingber | Chief Officer | Profile | |
| Rob Jackson | VP Marketing | Profile |